Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

28.25 -1.52 (-5.09%)
Streaming Delayed Price Updated: 2:26 PM EDT, Apr 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,595,812
Open 30.00
Bid (Size) 28.24 (500)
Ask (Size) 28.25 (900)
Prev. Close 29.76
Today's Range 28.05 - 30.05
52wk Range 13.74 - 70.43
Shares Outstanding 191,922,517
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program ↗
Telehealth investors weigh Amazon’s new anti-obesity drug push against this platform’s recent rapid growth, today, April 21, 2026. 
Via The Motley Fool
Topics Stocks
News headline image
A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly ↗
There might be room for two titans in the obesity business, but a third player might have a uniquely marketable option. 
Via The Motley Fool

Performance

YTD
-15.5%
-15.5%
1 Month
+25.8%
+25.8%
3 Month
-7.3%
-7.3%
6 Month
-42.8%
-42.8%
1 Year
+9.3%
+9.3%

More News

Read More
News headline image
What's Going On With Hims & Hers Shares ↗
Via Benzinga
News headline image
Stock Market Today, April 16: Hims & Hers Health Jumps on FDA Review of Compounded Peptide Therapies ↗
Via The Motley Fool
Topics Stocks
News headline image
Q4 Earnings Outperformers: Hims & Hers Health (NYSE:HIMS) And The Rest Of The Healthcare Technology Stocks
Via StockStory
News headline image
Did Hims & Hers Just Become an AI Company? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 Profitable Stocks with Exciting Potential and 1 We Ignore
Via StockStory
News headline image
3 Sectors to Buy While They're Down and 1 to Walk Away From ↗
Via MarketBeat
Topics Stocks
News headline image
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Should You Buy Hims Stock Today? ↗
Via The Motley Fool
News headline image
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
Via StockStory
Topics Government Stocks World Trade
News headline image
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know
Via StockStory
Topics Government Stocks
News headline image
2 Mooning Stocks on Our Buy List and 1 Facing Challenges
Via StockStory
Topics Initial Public Offering
News headline image
What's Happening With Novo Nordisk Stock Today? ↗
Via Benzinga
News headline image
Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers
From Hims & Hers
Via Business Wire
News headline image
Surging Oil Prices Spark Market Jitters ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
2 Healthcare Stocks to Target This Week and 1 That Underwhelm
Via StockStory
News headline image
This Hims & Hers Move Could Destroy Competitors ↗
Via The Motley Fool
News headline image
Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up? ↗
Via The Motley Fool
News headline image
1 Growth Stock with All-Star Potential and 2 That Underwhelm
Via StockStory
News headline image
Hims & Hers Opens Waitlist For $149 Branded Wegovy And Ozempic Via Novo Nordisk Deal ↗
Via Benzinga
News headline image
Hims & Hers (HIMS) 2026 Deep Dive: The $1.15B Eucalyptus Deal and the Branded Pivot
Via Finterra
Topics Intellectual Property
News headline image
Hims & Hers Opens Up Pre-Launch Waitlist For Ozempic And Wegovy Following Partnership With Novo Nordisk ↗
Via Stocktwits

Frequently Asked Questions

Is Hims & Hers Health, Inc. Class A Common Stock publicly traded?
Yes, Hims & Hers Health, Inc. Class A Common Stock is publicly traded.
What exchange does Hims & Hers Health, Inc. Class A Common Stock trade on?
Hims & Hers Health, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Hims & Hers Health, Inc. Class A Common Stock?
The ticker symbol for Hims & Hers Health, Inc. Class A Common Stock is HIMS on the New York Stock Exchange
What is the current price of Hims & Hers Health, Inc. Class A Common Stock?
The current price of Hims & Hers Health, Inc. Class A Common Stock is 28.25
When was Hims & Hers Health, Inc. Class A Common Stock last traded?
The last trade of Hims & Hers Health, Inc. Class A Common Stock was at 04/22/26 02:26 PM ET
What is the market capitalization of Hims & Hers Health, Inc. Class A Common Stock?
The market capitalization of Hims & Hers Health, Inc. Class A Common Stock is 5.42B
How many shares of Hims & Hers Health, Inc. Class A Common Stock are outstanding?
Hims & Hers Health, Inc. Class A Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.